|

|


MP International specialises in organising exhibitions, conferences and special events for various industries and interest groups. To date, the group has organised and managed more than 250 national, regional and international events. MP's success with various partners is a testimony of its ability to identify opportunities and maximise the rewards for win-win partnerships. This has won MP the distinction of being the only homegrown exhibition and conference organiser to receive the Enterprise 50 award for two consecutive years, in 2001 and 2002.
Moving forward, MP is committed to support fellow industry players through its association with the World Events Organisation (WEO). It is a founding partner of WEO, a regional network of professional event organisers. It is also a member of the PICO group. |
| More |
|
|
|

 |
MP has acquired Wine For Asia (WFA), Asia’s most comprehensive international wine exhibition. Future WFA shows will be organised by MP Wine Resources Pte Ltd, a new joint-venture set up by MP and Wine Resources.
WFA has become the must-visit regional wine event that wine distributors, importers, F&B and hospitality professionals mark on their calendars. It serves as an excellent showcase for exhibitors to promote their brands to the growing number of wine consumers.
WFA 2008 will be held at Suntec Singapore from 16 to 18 October. For more information, visit www.wineforasia.com.
|
|
|
 |
|
MP has set up a joint-venture company with Kenes International, a Geneva-based conference organiser with strong background in biomedical events, to form Kenes MP Asia Pte Ltd. The new company will focus on organising medical meetings in the Asia Pacific region.
Kenes International is an industry pioneer and leader in the field of congress organisation and association management services. It has organised over 1500 congresses during the last 42 years. Currently, it handles some 40 congresses a year.
The new joint-venture will enable Singapore to better anchor and develop biomedical events here and consolidate Singapore’s position as Asia’s biomedical hub.
|
|
|

|

|
|
|
|